EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

P21‐Activated Kinase 2 as a Novel Target for Ventricular Tachyarrhythmias Associated with Cardiac Adrenergic Stress and Hypertrophy

Tao Li, Ting Liu, Yan Wang, Yangpeng Li, Leiying Liu, James Bae, Yu He, Xian Luo, Zhu Liu, Tangting Chen, Xianhong Ou, Dan Zhang und 10 weitere

Advanced Science · 2025

DOI: 10.1002/advs.202411987 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, 2025. Verfasst von Tao Li und 21 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Medical Electrophysiology of the Ministry of Education, Medical Electrophysiological Key Laboratory of Sichuan Province, Institute …. Hauptthemen laut MEDLINE: p21-Activated Kinases, Cardiomegaly, Tachycardia, Ventricular. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Sichuan Science and Technology Program, Bureau of Science and Technology of Luzhou.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ventricular arrhythmias associated with cardiac adrenergic stress and hypertrophy pose a significant clinical challenge. We explored ventricular anti‐arrhythmic effects of P21‐activated kinase 2 (Pak2), comparing in vivo and ex vivo cardiomyocyte‐specific Pak2 knockout (Pak2 cko ) or overexpression (Pak2 ctg ) murine models, under conditions of acute adrenergic stress, and hypertrophy following chronic transverse aortic constriction (TAC). Pak2 was downregulated 5 weeks following the latter TAC challenge. Cellular physiological, optical action potential and Ca 2+ transient, measurements, demonstrated increased incidences of triggered ventricular arrhythmias, and prolonged action potential durations (APD) and altered Ca 2+ transients with increases in their beat‐to beat variations, in Pak2 cko hearts. Electron microscopic, proteomic, and molecular biological methods revealed a mitochondrial localization of stress‐related proteins on proteomic and phosphoproteomic analyses, particularly in TAC stressed Pak2 cko mice. They further yielded accompanying evidence for mitochondrial oxidative stress, increased reactive oxygen species (ROS) biosynthesis, reduced mitochondrial complexes I‐V, diminished ATP synthesis and elevated NADPH oxidase 4 (NOX4) levels. Pak2 overexpression and the novel Pak2 activator JB2019A ameliorated these effects, enhanced cardiac function and decreased the frequencies of triggered ventricular arrhythmias. Pak2 activation thus protects against ventricular arrhythmia associated with cardiac stress and hypertrophy, through unique mechanisms offering potential novel therapeutic anti‐arrhythmic targets.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

p21-Activated KinasesCardiomegalyTachycardia, VentricularAnimalsMiceMice, KnockoutMyocytes, CardiacDisease Models, AnimalOxidative StressMaleReactive Oxygen SpeciesMice, Inbred C57BL

Stichwörter der Autor:innen

Ca2+ handlingNADPH oxidaseP21‐activated kinase 2cardiac arrhythmiamitochondrial oxidative stress

Substanzen

p21-Activated KinasesPak2 protein, mouseReactive Oxygen Species

Autor:innen und Institutionen

  • Key Laboratory of Medical Electrophysiology of the Ministry of Education, Medical Electrophysiological Key Laboratory of Sichuan Province, Institute of Cardiovascular Research, Southwest Medical University, Luzhou, Sich…
  • Department of Cardiology, The Affiliated Hospital, Southwest Medical University, Luzhou, Sichuan, 646000, China.
  • Department of Pharmacology, University of Oxford, Mansfield Road, Oxford, OX1 3QT, UK.
  • Department of Cardiology, Zhongnan Hospital of Wuhan University, East Lake Road 169, Wuhan, 430071, China.
  • Faculty of Biology, Medicine and Health, The University of Manchester, Dover Street, Manchester, M13 9GB, UK.
  • Laboratory of Mitochondria and Metabolism, West China Hospital of Sichuan University, Chengdu, 610041, China.

ORCID-Profile: Xiaoqiu Tan

Förderung

  • National Natural Science Foundation of China
  • Sichuan Science and Technology Program
  • Bureau of Science and Technology of Luzhou
  • British Heart Foundation

Zitieren

APA

Li, T., Liu, T., Wang, Y., Li, Y., Liu, L., Bae, J., He, Y., Luo, X., Liu, Z., Chen, T., Ou, X., Zhang, D., Lan, H., Wan, J., Wei, Y., Zhao, F., Wang, X., Li, T., Huang, C. L., …, & Tan, X. (2025). P21‐Activated Kinase 2 as a Novel Target for Ventricular Tachyarrhythmias Associated with Cardiac Adrenergic Stress and Hypertrophy. Advanced Science. https://doi.org/10.1002/advs.202411987

Vancouver

Li T, Liu T, Wang Y, Li Y, Liu L, Bae J, et al. P21‐Activated Kinase 2 as a Novel Target for Ventricular Tachyarrhythmias Associated with Cardiac Adrenergic Stress and Hypertrophy. Advanced Science. 2025. doi:10.1002/advs.202411987

BibTeX
@article{Li2025,
  author = {Li, Tao and Liu, Ting and Wang, Yan and Li, Yangpeng and Liu, Leiying and Bae, James and He, Yu and Luo, Xian and Liu, Zhu and Chen, Tangting and Ou, Xianhong and Zhang, Dan and Lan, Huan and Wan, Juyi and Wei, Yan and Zhao, Fang and Wang, Xin and Li, Tao and Huang, Christopher L-H and Zhang, Chunxiang and Lei, Ming and Tan, Xiaoqiu},
  title = {P21‐Activated Kinase 2 as a Novel Target for Ventricular Tachyarrhythmias Associated with Cardiac Adrenergic Stress and Hypertrophy},
  journal = {Advanced Science},
  year = {2025},
  doi = {10.1002/advs.202411987}
}
Kostenlos starten →